Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic Kinga MajchrzakMichelle H. NelsonChrystal M. Paulos Review 29 January 2016 Pages: 247 - 259
Identification of the murine H-2Db and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes Shiwen PengAustin MattoxSara I. Pai Original Article 13 January 2016 Pages: 261 - 271
The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib Annkristin HeineJudith SchillingBastian Höchst Original Article 19 January 2016 Pages: 273 - 282
Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells David PaleschJohanna WagnerTimo Burster Original Article 02 February 2016 Pages: 283 - 291
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors Timothy T. SpearGlenda G. CallenderMichael I. Nishimura Original Article 03 February 2016 Pages: 293 - 304
Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155 Baofu ZhangWeina ZhaoJunnian Zheng Original Article 03 February 2016 Pages: 305 - 314
The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity Daphné LaubretonSylvie BayClaude Leclerc Original Article Open access 04 February 2016 Pages: 315 - 325
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity Kalijn F. BolErik H. J. G. AarntzenGerty Schreibelt Original Article Open access 10 February 2016 Pages: 327 - 339
Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model Toshihiro SuzukiHidehiro KishimotoRyo Abe Original Article 15 February 2016 Pages: 341 - 354
Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway Davide BommaritoAllison MartinRoberto Bellucci Original Article 16 February 2016 Pages: 355 - 366